PCR based mutagenesis will be used to selectively alter the amino acid sequence of wild type horse cytochrome c and a variant, H33N, which lacks a non-native histidine ligand of the heme iron and thus exhibits a simplified folding mechanism. Twelve evolutionarily conserved sites in the structural core of the protein, which are unlikely to contribute to function, have been identified for mutagenesis. Mutant proteins will be expressed using a yeast strain which lacks cytochrome c. Recombinant protein purified by NaCI-ethyl acetate precipitation, Amberlite CG-50 chromatography, ultrafiltration and FPLC, will be examined for solubility, stability, and folding - unfolding equilibrium. Tryptophan fluorescence will assess structural stability. This method provides an indication of the overall dimensions of cytochrome c since the single tryptophan in the polypeptide is fluorescent in the unfolded state but loses fluorescence in the native state as a result of energy transfer to heme. Far UV CD spectroscopy will monitor the equilibria of folding and unfolding under various conditions of denaturation and temperature.

Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
Small Research Grants (R03)
Project #
5R03TW000785-03
Application #
2883764
Study Section
International and Cooperative Projects 1 Study Section (ICP)
Program Officer
Michels, Kathleen M
Project Start
1997-03-01
Project End
2000-02-29
Budget Start
1999-03-01
Budget End
2000-02-29
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Institute for Cancer Research
Department
Type
DUNS #
872612445
City
Philadelphia
State
PA
Country
United States
Zip Code
19111